Optimizing Physiochemical, Potency and Impurity Analytical Methods to Enhance Product Understanding and Quality to Support Regulatory Submissions

Time: 08:00 AM – 03:45 PM

Venue Details: Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States

Prices:
Drug Developer – Conference Day Only: USD 2999.00,
Drug Developer – Conference + Workshop Day: USD 4297.00,
Academic – Conference Day Only: USD 2599.00,
Academic – Conference + Workshop Day: USD 3697.00,
Solution Provider – Conference Day Only: USD 3699.00,
Solution Provider + Workshop Day: USD 5097.00

Speakers: Allison Torgesen, Quality Control Director, Bolt Biotherapeutics, Amit Katiyar, Senior Director – Late Stage Biologics, Exelixis, Chen Qiu, Chemistry, Manufacturing and Controls Scientist, Takeda, Chris Chumsae, Director of Biophysical-Chemical Characterization, Bristol Myers Squibb, Chris Woods, Scientist, Analytical Development, Seagen, Chuan Leng, Associate Principal Scientist, Merck and Co, David Lee, Executive Director, Analytical Chemistry, Mersana Therapeutics, Delphine Peric, Bioassay Laboratory Supervisor, Sanofi, Dengyun (Daisy) Sun, Principal Scientist, Merck and Co, Diego Arturo Alonzo Muniz, Scientist, Analytic (Mass Spectrometry), Zymeworks, Halei Zhai, Senior Scientist – Analytical Development, Chemistry, Manufacturing and Controls, Bolt Biotherapeutics, Linda Nelson, Executive Director, Daiichi Sankyo, Lizzy Zhao, Senior Scientist, Regeneron, Madhumati Mukherjee, Senior Scientist, AstraZeneca, Manghong Zhu, Scientist, Mersana Therapeutics, Mark Eggink, Principal Scientist, Byondis, Melvin Flores, Associate Director, Quality Control Analytical, Sutro Biopharma, Mysore Ramprasad, Executive Director, Pharmaceutical and Analytical Development, Ambrx, Nailing Zhang, Lead Biologist, FDA, Qin Yan, Senior Scientist, AstraZeneca, Ray Lin Director, Potency Assay Department, Seagen, Renpeng Liu, Principal Scientist, Pyxis Oncology, Weijun Li, Senior Director Biologics Analytical Development / CMC Team Lead, Exelixis, Yan-Hui Liu Director, Analytical Development, Drug Product and Anti-Oxidant, Strategic External Development, GSK, Yuan Gao, Head of Analytical Development, ADC Therapeutics